Elekta highlights ASTRO data showing 37.4% two-year survival in localized pancreatic cancer patients treated on Unity MR-Linac
Bitget2026/09/28 17:02- Elekta flagged clinical results already presented at ASTRO 2026 on its Unity MR-Linac in localized pancreatic cancer.
- The Memorial Sloan Kettering study tracked non-surgical patients, showing durable tumor control with encouraging longer-term survival.
- Findings support broader uptake of MR-guided adaptive radiotherapy, a key growth area for Elekta’s high-end radiotherapy franchise.
- Elekta is advancing Unity with Unity Pro to speed workflows, aiming to make daily adaptive treatments more practical across centers.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Besent “Extinguishes Fire”: Rising US Treasury yields are a global phenomenon, dismisses concerns over AI bubble
U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.